HYDROVAL OINTMENT 0.2% 0.2 %
HYDROCORTISONE VALERATE : 0.2 % · DIN 02242985 · TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
Health Canada status: MARKETED
What is HYDROVAL OINTMENT 0.2%?
HYDROVAL OINTMENT 0.2% 0.2 % contains HYDROCORTISONE VALERATE : 0.2 %. It is listed in the Health Canada Drug Product Database under DIN 02242985, held by TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC., supplied as OINTMENT for TOPICAL administration. Health Canada currently lists it as marketed, status dated 06-Apr-2004. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is HYDROVAL OINTMENT 0.2% used for?
Topical therapy of acute and chronic corticosteroid responsive dermatoses where anti-inflammatory, anti-allergenic, and antipruritic activity is required.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
What else is HYDROVAL OINTMENT 0.2% called?
The same molecule, HYDROCORTISONE, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Alfacort | Latin | Bahrain, Saudi Arabia, United Arab Emirates |
| HYDROCORTISON VUAB | Latin | Czechia |
| Dilucort | Latin | South Africa |
| HYDROCORTISONE LEURQUIN | Latin | Morocco |
| Macleods Hydrocortisone Injection | Latin | South Africa |
| Softacort | Latin | Czechia, Iceland |
| Terracortril | Latin | South Africa |
| Acecort | Latin | Norway |
| CANDICORT CREAM | Latin | Saudi Arabia |
| COLIRCUSI H.C WITH NEOM | Latin | Saudi Arabia |
| CORTIDERM | Latin | Bahrain |
| Cortotic Vet | Latin | Iceland |
| Covocort | Latin | South Africa |
| Daktacort | Latin | South Africa |
| EFFICORT HYDROPHILE | Latin | Morocco |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02242985 |
|---|---|
| Brand name | HYDROVAL OINTMENT 0.2% |
| Generic / active ingredient | HYDROCORTISONE VALERATE : 0.2 % |
| Manufacturer | TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC. |
| Strength | 0.2 % |
| Dosage form | OINTMENT |
| Route of administration | TOPICAL |
| Schedule | Prescription |
| ATC code | D07AA02 HYDROCORTISONE |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 06-Apr-2004 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02242985 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2242985 |
| Brand name | HYDROVAL OINTMENT 0.2% |
| Active ingredient / INN | HYDROCORTISONE VALERATE : 0.2 % |
| ATC code | D07AA02 |
| ATC anatomical main group | D — Dermatologicals |
| ATC therapeutic subgroup | D07 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC. |
How is it administered?
Apply a small amount to affected areas 2 to 3 times daily as needed. Rub in gently and completely. Discontinue as soon as lesions heal. Do not use under occlusive dressings unless directed.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store at controlled room temperature (15-25°C).
How is it supplied?
Cream: tubes of 15, 45, and 60 g. Ointment: tubes of 15 and 60 g.
Which pack is which?
| Strength on the label | 0.2 % |
|---|---|
| Dosage form | OINTMENT |
| Route | TOPICAL |
| Packaging as described in the monograph | Cream: tubes of 15, 45, and 60 g. Ointment: tubes of 15 and 60 g. |
| Storage | Store at controlled room temperature (15-25°C). |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Contraindications
Hypersensitivity to components; bacterial/fungal skin infections, tuberculosis of skin, syphilitic skin infections, chicken pox, viral diseases of the skin. Not for ophthalmic use.
Warnings and precautions
Systemic absorption can cause HPA axis suppression, Cushing’s syndrome, and adrenal suppression, especially with occlusive dressings, extensive areas, or use on the face/axillae.
What can be used instead?
Other Canadian products sharing ATC code D07AA02 HYDROCORTISONE. 3 of 34 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| HYDROVAL CREAM 0.2% | 0.2 % | CREAM | TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC. | MARKETED | DIN 02242984 |
| SANDOZ HYDROCORTISONE | 2.5 % | CREAM | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02469421 |
| ALOCORT 1% - CRM | 1 % | CREAM | UCB INC | CANCELLED POST MARKET | DIN 02176408 |
| AQUACORT LOTION 2.5% | 2.5 % | LOTION | MERIT INDUSTRIES INC. | CANCELLED POST MARKET | DIN 01940120 |
| AVEENO HYDROCORTISONE ANTI-ITCH CREAM | 0.5 % | CREAM | JOHNSON & JOHNSON INC | CANCELLED POST MARKET | DIN 02244959 |
| BARRIERE HC 1% | 1 % | JELLY ; CREAM | ALLEN & HANBURYS A GLAXO CANADA LTD. CO. | CANCELLED POST MARKET | DIN 00465070 |
| CORTACET CRM 0.5% | 0.5 % | CREAM | WHITEHALL-ROBINS INC. | CANCELLED POST MARKET | DIN 01932381 |
| CORTATE CRM 1% | 10 MG | CREAM | SCHERING-PLOUGH CANADA INC | CANCELLED POST MARKET | DIN 00502200 |
| CORTATE ONT 1% | 10 MG | OINTMENT | SCHERING-PLOUGH CANADA INC | CANCELLED POST MARKET | DIN 00502197 |
| CORTICREME 0.1% | 1 MG | CREAM | ROUGIER PHARMA DIVISION OF RATIOPHARM INC | CANCELLED POST MARKET | DIN 00477680 |
Who else supplies HYDROCORTISONE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. HYDROCORTISONE appears in 37 registered pack listings across 7 markets, published on 6 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does HYDROCORTISONE cost around the world?
HYDROCORTISONE is listed on 15 national price registers Nexara tracks, across 183 pack listings published on 14 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| United States | acquisition | 11 | 71 | 03 Sep 2026 |
| South Africa | single exit price | 15 | 22 | 01 Sep 2026 |
| Saudi Arabia | public | 16 | 16 | 01 Sep 2026 |
| Greece | producer price (ex-factory) | 15 | 15 | 03 Sep 2026 |
| Austria | KVP (Kassenverkaufspreis) | 9 | 9 | 03 Sep 2026 |
| Czechia | max producer price (ex-factory) | 5 | 9 | 03 Sep 2026 |
| Australia | ex-manufacturer | 4 | 8 | 08 Sep 2026 |
| United Arab Emirates | public | 4 | 6 | 31 Aug 2026 |
| Bahrain | retail (max) | 4 | 6 | 01 Sep 2026 |
| Morocco | PPV (public price) | 5 | 6 | 05 Sep 2026 |
| United Kingdom | hospital | 5 | 5 | 31 Aug 2026 |
| Luxembourg | reimbursement | 4 | 4 | 05 Sep 2026 |
| Iceland | max wholesale | 3 | 3 | 02 Sep 2026 |
| Norway | max AUP (pharmacy retail) | 2 | 2 | 07 Sep 2026 |
| Lebanon | public price (USD, Decision 119/1) | 1 | 1 | 02 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.